Year: 2025
Type: article
Abstract: Medication use during pregnancy is common, yet safety data remain limited, often leading to exaggerated risk perceptions and suboptimal care. Current communication practices are fragmented: product labeling and patient leaflets tend to emphasize potential harms, while specialized resources are underused. We explore the challenges of conveying accurate risk-benefit information and highlight the need for shared decision making. Integrated, evidence-based resources accessible to both healthcare providers and patients can reduce misinformation, improve adherence to essential treatments, and ultimately enhance maternal and child health. The Swiss MAMA-MEDS initiative illustrates how a unified knowledge base can align messaging, address health inequalities, and support patient-centered pregnancy care.
Institutions: Centre Hospitalier Universitaire Vaudois, Royal Victoria Infirmary, Tel Aviv University, Inserm, Sorbonne Université, Hôpital Armand-Trousseau, Assistance Publique – Hôpitaux de Paris, Institut Pierre Louis d‘Épidémiologie et de Santé Publique, Radboud University Medical Center, KU Leuven, Humboldt-Universität zu Berlin, Charité - Universitätsmedizin Berlin, University of Lausanne, University of Bern
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,353
OpenAlex ID: W4415237152